Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

CHARACTERIZATION OF PREEXISTING HIV-SPECIFIC CD4 T CELLS IN UNINFECTED INDIVIDUALS

By Enthusiast Inc MDFebruary 16, 2017

…follicular helper cells (median 20% vs. 14%), and preferentially expressed CXCR3 (median 46% vs. 35%). There was a direct correlation between the magnitudes of HIV-specific TH measured by the AIM…

Shaping CTL Immunodominance With Conserved HIV Vaccines After Early Treatment (BCN01)

By Enthusiast Inc MDFebruary 16, 2016

…TDF/FTC/RAL 1 wk after diagnosis. Individuals received ChAdV63.HIVconsv (5×1010vp, im) and MVA.HIVconsv (2×108pfu, im) 8 or 24 wk after (Short vs Long regimen) and were followed for 6 months. Immunogenicity…

IN MEMORIAM: Dr David A. Katzenstein (1952-2021)

Latest NewsBy Michelle ValderamaJanuary 27, 2021

Share Your Thoughts Please join us in remembering the extraordinary life of Dr David A. Katzenstein by leaving your message of condolence and sharing your stories, memories, and photos. In…

684 – What Do Early Adopters of Long-Acting Injectable Cabotegravir/Rilpivirine Think About It?

By Jimmy He PharmD, DScMarch 20, 2025

…instability, and 22% with substance use. Median number of injections was 9 (IQR 5,14). Mean (SD) satisfaction using LA-CAB/RPV was 61.5/66 (5.3), and 74% reported mental well-being as better with…

393 – Single-Cell Analysis Identifies Broad Immune Alterations Despite ART-Induced Viral Suppression

By Jimmy He PharmD, DScMarch 31, 2026

…the relationship is damped in mesenteric lymph node, suggesting a uniquely immunosuppressive environment that could enhance viral persistence. IFN signatures decayed rapidly after ART initiation, although remained elevated in lymphoid…

ALTERED AND INCOMPLETE IMMUNE RECONSTITUTION IN HIV+ STEM CELL TRANSPLANT RECIPIENTS

By Enthusiast Inc MDMarch 5, 2018

…on antiretroviral therapy (ART), there has been little evaluation of the kinetics of immune reconstitution. We prospectively evaluated HIV and CMV viral loads, and immune reconstitution measured by CD4 and…

THERAPEUTIC VACCINATION OF SHIV-INFECTED, ART-SUPPRESSED INFANT RHESUS MACAQUES

By Jimmy He PharmD, DScMarch 24, 2023

…otherwise must be on ART for their lifetime. The objective of this study was to evaluate the immunological and virological impact of DNA/MVA/Protein-based therapeutic vaccination in a pediatric model of…

Directing Chronic Virus Infection Through Viral Regulation of Innate Immune Defenses

By Enthusiast Inc MDFebruary 24, 2015

…innate immune signaling outcomes within cells infected with HCV or HIV defines viral regulation of IRF3, and suppression of ISG products, as shared feature of chronic virus infection. Our studies…

CD4 DEPLETION IN SIV-INFECTED MACAQUES ON EARLY ART HAS NO IMPACT ON VIRAL REBOUND

By Enthusiast Inc MDMarch 5, 2018

…initiation, plasma viral loads in all animals were stably suppressed to <15 viral RNA copies/ml. Consistent with limited reservoir establishment, cell-associated vDNA measurements were low in PBMC (median 1.7 vDNA…

Clonal Expansion and Driving Forces of HIV-1 Persistence in Anatomic Compartments

By Jimmy He PharmD, DScMarch 6, 2024

Background: Upon infection, HIV quickly disseminates and establishes persistent infection throughout the body. The persistence mechanisms of HIV in tissues are complex, with viral and local environment interaction contributing to…

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758
…5960616263…
64656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top